GSK | ||
---|---|---|
OUTLOOK RATING 1..100 | 23 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 64 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 50 | |
P/E GROWTH RATING 1..100 | 25 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FLGB | GSK | |
---|---|---|
RSI ODDS (%) | 1 day ago73% | 1 day ago66% |
Stochastic ODDS (%) | 1 day ago77% | 1 day ago38% |
Momentum ODDS (%) | 1 day ago86% | 1 day ago58% |
MACD ODDS (%) | 1 day ago82% | 1 day ago60% |
TrendWeek ODDS (%) | 1 day ago83% | 1 day ago59% |
TrendMonth ODDS (%) | 1 day ago80% | 1 day ago53% |
Advances ODDS (%) | 7 days ago83% | 6 days ago58% |
Declines ODDS (%) | 21 days ago74% | 15 days ago54% |
BollingerBands ODDS (%) | 1 day ago83% | 1 day ago43% |
Aroon ODDS (%) | 1 day ago81% | 1 day ago48% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UVIX | 14.10 | 0.58 | +4.29% |
2x Long VIX Futures ETF | |||
UTSL | 42.41 | 1.19 | +2.89% |
Direxion Daily Utilities Bull 3X ETF | |||
FLCV | 29.89 | 0.07 | +0.23% |
Federated Hermes MDT Large Cap Value ETF | |||
BOXX | 113.30 | N/A | N/A |
Alpha Architect 1-3 Month Box ETF | |||
AVGV | 68.08 | -0.06 | -0.10% |
Avantis All Equity Markets Value ETF |
A.I.dvisor indicates that over the last year, FLGB has been loosely correlated with EVR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if FLGB jumps, then EVR could also see price increases.
Ticker / NAME | Correlation To FLGB | 1D Price Change % | ||
---|---|---|---|---|
FLGB | 100% | -0.08% | ||
EVR - FLGB | 47% Loosely correlated | -0.92% | ||
WIX - FLGB | 31% Poorly correlated | -1.67% | ||
NG - FLGB | 26% Poorly correlated | -2.31% | ||
RIO - FLGB | 25% Poorly correlated | +0.38% | ||
GSK - FLGB | 24% Poorly correlated | +1.41% | ||
More |
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.